Toggle Main Menu Toggle Search

Open Access padlockePrints

Auditory and vestibular function in mitochondrial patients harbouring the m.3243A>G variant

Lookup NU author(s): Dr Renae StefanettiORCiD, Jane Newman, Dr Alasdair Blain, Professor Grainne Gorman

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2024 The Author(s).Hearing impairment is a frequent clinical feature in patients with mitochondrial disease harbouring the pathogenic variant, m.3243A>G. However, auditory neural dysfunction, its perceptual consequences and implications for patient management are not established. Similarly, the association with vestibular impairment has not yet been explored. This case-control study investigated in 12 adults with genetically confirmed m.3243A>G adults [9 females; 45.5 ± 16.3 years (range 18-66); 47.1 ± 21.5 hearing level, dB] compared with 12 age, sex and hearing level-matched controls with sensory (cochlear level) hearing loss [9 females; 46.6 ± 11.8 years (range 23-59); 47.7 ± 25.4 hearing level, dB]. Participants underwent a battery of electroacoustic, electrophysiologic and perceptual tests, which included pure tone audiometry, otoacoustic emissions, auditory brainstem responses, auditory temporal processing measures, monaural/binaural speech perception, balance and vestibular testing and self-reported questionnaires (dizziness and hearing disability). Our findings showed evidence of auditory neural abnormality and perceptual deficits greater than expected for cochlear pathology. Compared with matched controls with sensory hearing loss, adults with mitochondrial disease harbouring m.3243A>G had abnormal electrophysiologic responses from the VIII nerve and auditory brainstem (P = 0.005), an impaired capacity to encode rapidly occurring acoustic signal changes (P = 0.005), a reduced ability to localize sound sources (P = 0.028) and impaired speech perception in background noise (P = 0.008). Additionally, vestibular dysfunction (P = 0.011), greater perceived dizziness (P = 0.001) and reduced stance time (balance, P = 0.009) were also seen in participants with m.3243A>G mitochondrial disease when compared with matched counterparts. This pilot study revealed that auditory evaluation including evoked potential responses from the auditory nerve/brainstem and speech perception in noise tests should form an important part of the management for individuals with m.3243A>G-related mitochondrial disease. Those presenting with hearing impairment and symptoms concerning balance and dizziness should undergo vestibular testing and appropriate management.


Publication metadata

Author(s): Stefanetti RJ, Newman J, Blain AP, Chisari D, Gorman GS, Rance G

Publication type: Article

Publication status: Published

Journal: Brain Communications

Year: 2024

Volume: 6

Issue: 6

Online publication date: 14/10/2024

Acceptance date: 10/10/2024

Date deposited: 25/11/2024

ISSN (electronic): 2632-1297

Publisher: Oxford University Press

URL: https://doi.org/10.1093/braincomms/fcae361

DOI: 10.1093/braincomms/fcae361

Data Access Statement: Data will be shared upon request with suitably qualified researchers. The corresponding author (G.R.) has full access to the data in the study. Study data will be shared upon request, while maintaining anonymization of participants.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
[Applied Research Collaboration (ARC)
Biotechnology and Biological Sciences Research Council
MRC
North East and North Cumbria (NENC)
Wellcome Centre for Mitochondrial Research (WCMR; 203105)

Share